Kyverna Therapeutics Inc (KYTX) Stock Price, Quote & News

Latest News on KYTX

Jan 17, 2025, 9:15 AM EST - 18 hours ago

Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Jan 16, 2025, 11:30 AM EST - 1 day ago

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics Inc.

Jan 16, 2025, 5:45 AM EST - 1 day ago

Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights - KYTX

Jan 15, 2025, 11:28 AM EST - 2 days ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

Jan 14, 2025, 11:45 AM EST - 3 days ago

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics Inc

Jan 13, 2025, 7:30 AM EST - 4 days ago

Kyverna Therapeutics to Highlight Near-Term Strategic Priorities and Key Milestones at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 11:30 AM EST - 9 days ago

Kyverna Therapeutics Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Jan 7, 2025, 9:08 PM EST - 10 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

Jan 7, 2025, 12:15 PM EST - 10 days ago

The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics, Inc.

Jan 6, 2025, 4:05 PM EST - 11 days ago

Kyverna Therapeutics to Present at the 43rd Annual J. P. Morgan Healthcare Conference

Jan 6, 2025, 11:30 AM EST - 11 days ago

Kyverna Therapeutics Inc Is Being Sued For Securities Law Violations And Impacted Investors Are Urged To Contact The Schall Law Firm

Jan 4, 2025, 11:45 AM EST - 13 days ago

Kyverna Therapeutics Inc Is Being Sued For Securities Law Violations And Affected Investors Are Encouraged To Contact The Schall Law Firm

Jan 3, 2025, 11:30 AM EST - 14 days ago

The Schall Law Firm Urges Shareholders With Losses To Join A Securities Fraud Case Against Kyverna Therapeutics Inc

Jan 2, 2025, 11:30 AM EST - 15 days ago

Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Affected Investors Are Invited To Contact The Schall Law Firm

Dec 30, 2024, 11:30 AM EST - 18 days ago

Kyverna Therapeutics, Inc. Is Being Sued For Securities Law Violations And Impacted Investors Are Invited To Contact The Schall Law Firm

Dec 29, 2024, 11:00 AM EST - 19 days ago

The Schall Law Firm Urges Shareholders To Take Part In A Securities Fraud Case Against Kyverna Therapeutics Inc

Dec 27, 2024, 12:30 PM EST - 21 days ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc

Dec 24, 2024, 8:10 AM EST - 24 days ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics

Dec 20, 2024, 1:45 PM EST - 4 weeks ago

Kyverna Therapeutics Inc. Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Contact The Schall Law Firm

Dec 19, 2024, 5:45 AM EST - 4 weeks ago

Kyverna Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights - KYTX

Dec 18, 2024, 10:03 PM EST - 4 weeks ago

The Schall Law Firm Urges Shareholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc.

Dec 17, 2024, 7:15 PM EST - 4 weeks ago

Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Assist The Schall Law Firm

Dec 16, 2024, 6:15 PM EST - 4 weeks ago

The Schall Law Firm Urges Stockholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc

Dec 16, 2024, 5:45 AM EST - 4 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. Lawsuit - KYTX

Dec 15, 2024, 9:00 PM EST - 4 weeks ago

Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Affected Investors Are Invited To Contact The Schall Law Firm

Dec 14, 2024, 7:10 PM EST - 4 weeks ago

The Schall Law Firm Encourages Stockholder Participation In A Securities Fraud Case Against Kyverna Therapeutics Inc

Dec 13, 2024, 7:30 PM EST - 5 weeks ago

Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Contact The Schall Law Firm

Dec 13, 2024, 4:05 PM EST - 5 weeks ago

Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth

Dec 12, 2024, 2:03 PM EST - 5 weeks ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Kyverna Therapeutics, Inc. (KYTX) on Behalf of Investors

Dec 11, 2024, 8:45 PM EST - 5 weeks ago

Kyverna Therapeutics, Inc. Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Reach Out To The Schall Law Firm

Dec 11, 2024, 7:04 PM EST - 5 weeks ago

The Law Offices of Frank R. Cruz Announces Investigation of Kyverna Therapeutics, Inc. (KYTX) on Behalf of Investors

Dec 10, 2024, 6:12 PM EST - 5 weeks ago

Kyverna Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. February 7, 2025 Deadline to file Lead Plaintiff Motion.

Dec 10, 2024, 4:19 PM EST - 5 weeks ago

Rosen Law Firm Urges Kyverna Therapeutics, Inc. (NASDAQ: KYTX) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Market Cap	148.08M
Revenue (ttm)	0.00
Net Income (ttm)	-60.37M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	183,200
Avg Vol	340,986
Day's Range	N/A - N/A
Shares Out	43.17M
Stochastic %K	2%
Beta	N/A
Analysts	Strong Sell
Price Target	$25.71